Choroidal neovascularization (CNV) treatment is a procedure used to control the abnormal growth of blood vessels in the choroid layer of the eye. This condition is often associated with age-related macular degeneration (AMD), diabetic retinopathy, or retinal vein occlusion.

The treatment typically involves intravitreal injections of anti-VEGF (vascular endothelial growth factor) medications, which inhibit the growth of abnormal blood vessels, or laser therapy to seal leaking vessels.

CNV treatment is essential to prevent further vision loss and to stabilize the condition, significantly improving the quality of life for patients with retinal vascular diseases.